A

Adrestia Therapeutics

36 employees

Adrestia is developing therapeutics that work in an entirely new way – restoring the biological balance in damaged, diseased or dying cells

Basic info

Industry

biotechnology research

Sectors

geneticmedicine and syntheticrescue
Biotechnology

Date founded

2018

Funding rounds raised

Total raised

$232M

from 2 investors over 2 rounds

A

Adrestia Therapeutics raised $232M on December 18, 2020

Investors: Ahren Innovation Capital

A

Adrestia Therapeutics raised undisclosed on September 3, 2018

Investors: Ahren Innovation Capital

FAQ